Top Oversold U.S.-Listed Chinese Stocks (Jan 11, 2012)

XCSFDHG46767FHJHJF

tdp2664 China Analyst Below are the latest oversold U.S.-listed Chinese stocks. Perfect World Co., Ltd. (ADR) (NASDAQ:PWRD) is the most oversold U.S.-listed Chinese stock on Jan. 11. It was down 3.0% on the day. PWRD's upside potential is 135.1% based on brokerage analysts' average target price of $24.00. It is trading at 35.1% of its 52-week high of $29.10, and 21.0% above its 52-week low of $8.44. AsiaInfo-Linkage, Inc. (NASDAQ:ASIA) is the second most oversold U.S.-listed Chinese stock on Jan. 11. It was down 2.2% on the day. ASIA's upside potential is 121.3% based on brokerage analysts' average target price of $17.44. It is trading at 34.4% of its 52-week high of $22.91, and 26.9% above its 52-week low of $6.21. Huaneng Power International, Inc. (ADR) (NYSE:HNP) is the third most oversold U.S.-listed Chinese stock on Jan. 11. It was down 2.2% on the day. HNP's upside potential is 4.5% based on brokerage analysts' average target price of $23.32. It is trading at 93.2% of its 52-week high of $23.94, and 44.4% above its 52-week low of $15.45. China Kanghui Holdings (ADR) (NYSE:KH) is the fourth most oversold U.S.-listed Chinese stock on Jan. 11. It was down 1.1% on the day. KH's upside potential is 67.2% based on brokerage analysts' average target price of $24.75. It is trading at 55.8% of its 52-week high of $26.50, and 14.6% above its 52-week low of $12.92. WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) is the fifth most oversold U.S.-listed Chinese stock on Jan. 11. It was down 1.0% on the day. WX's upside potential is 51.2% based on brokerage analysts' average target price of $18.54. It is trading at 64.2% of its 52-week high of $19.10, and 15.1% above its 52-week low of $10.65. CNinsure Inc. (ADR) (NASDAQ:CISG) is the sixth most oversold U.S.-listed Chinese stock on Jan. 11. It was down 0.9% on the day. CISG's upside potential is 199.4% based on brokerage analysts' average target price of $20.36. It is trading at 32.6% of its 52-week high of $20.88, and 28.8% above its 52-week low of $5.28. China Lodging Group, Ltd (ADR) (NASDAQ:HTHT) is the seventh most oversold U.S.-listed Chinese stock on Jan. 11. It was down 0.7% on the day. HTHT's upside potential is 61.5% based on brokerage analysts' average target price of $21.82. It is trading at 55.4% of its 52-week high of $24.38, and 12.6% above its 52-week low of $12.00. CNOOC Limited (ADR) (NYSE:CEO) is the eighth most oversold U.S.-listed Chinese stock on Jan. 11. It was down 0.6% on the day. CEO's upside potential is 13.5% based on brokerage analysts' average target price of $221.93. It is trading at 71.9% of its 52-week high of $271.94, and 38.4% above its 52-week low of $141.27. Simcere Pharmaceutical Group (ADR) (NYSE:SCR) is the ninth most oversold U.S.-listed Chinese stock on Jan. 11. It was down 0.6% on the day. SCR's upside potential is 11.3% based on brokerage analysts' average target price of $9.98. It is trading at 65.2% of its 52-week high of $13.75, and 26.0% above its 52-week low of $7.12. Giant Interactive Group Inc (ADR) (NYSE:GA) is the 10th most oversold U.S.-listed Chinese stock on Jan. 11. It was down 0.5% on the day. GA's upside potential is 74.0% based on brokerage analysts' average target price of $6.98. It is trading at 42.4% of its 52-week high of $9.45, and 32.8% above its 52-week low of $3.02. China Petroleum & Chemical Corp. (ADR) (NYSE:SNP) is the 11th most oversold U.S.-listed Chinese stock on Jan. 11. It was down 0.5% on the day. SNP's upside potential is 5.6% based on brokerage analysts' average target price of $122.20. It is trading at 98.5% of its 52-week high of $117.40, and 40.2% above its 52-week low of $82.50. Mindray Medical International Ltd (ADR) (NYSE:MR) is the 12th most oversold U.S.-listed Chinese stock on Jan. 11. It was down 0.4% on the day. MR's upside potential is 6.8% based on brokerage analysts' average target price of $31.13. It is trading at 93.4% of its 52-week high of $31.21, and 37.2% above its 52-week low of $21.25. China Mobile Ltd. (ADR) (NYSE:CHL) is the 13th most oversold U.S.-listed Chinese stock on Jan. 11. It was down 0.3% on the day. CHL's upside potential is 1.1% based on brokerage analysts' average target price of $49.97. It is trading at 95.1% of its 52-week high of $51.98, and 13.6% above its 52-week low of $43.51.